MRI in Pregnancy and Precision Medicine: A Review from Literature
Gianluca Gatta,Graziella Di Grezia,Vincenzo Cuccurullo,Celestino Sardu,Francesco Iovino,Rosita Comune,Angelo Ruggiero,Marilena Chirico,Daniele La Forgia,Annarita Fanizzi,Raffaella Massafra,Maria Paola Belfiore,Giuseppe Falco,Alfonso Reginelli,Luca Brunese,Roberto Grassi,Salvatore Cappabianca,Luigi Viola
DOI: https://doi.org/10.3390/jpm12010009
IF: 3.5083
2021-12-23
Journal of Personalized Medicine
Abstract:Magnetic resonance imaging (MRI) offers excellent spatial and contrast resolution for evaluating a wide variety of pathologies, without exposing patients to ionizing radiations. Additionally, MRI offers reproducible diagnostic imaging results that are not operator-dependent, a major advantage over ultrasound. MRI is commonly used in pregnant women to evaluate, most frequently, acute abdominal and pelvic pain or placental abnormalities, as well as neurological or fetal abnormalities, infections, or neoplasms. However, to date, our knowledge about MRI safety during pregnancy, especially about the administration of gadolinium-based contrast agents, which are able to cross the placental barrier, is still limited, raising concerns about possible negative effects on both the mother and the health of the fetus. Contrast agents that are unable to cross the placenta in a way that is safe for the fetus are desirable. In recent years, some preclinical studies, carried out in rodent models, have evaluated the role of long circulating liposomal nanoparticle-based blood-pool gadolinium contrast agents that do not penetrate the placental barrier due to their size and therefore do not expose the fetus to the contrast agent during pregnancy, preserving it from any hypothetical risks. Hence, we performed a literature review focusing on contrast and non-contrast MRI use during pregnancy.
medicine, general & internal,health care sciences & services